Download Files:
Cediranib (maleate)
SKU
HY-13049-10 mg
Category Reference compound
Tags Autophagy;PDGFR;VEGFR, Autophagy;Protein Tyrosine Kinase/RTK, Cancer
$50 – $380
Products Details
Product Description
– Cediranib maleate (AZD-2171 maleate) is a highly potent, orally available VEGFR inhibitor with IC50s of <1, <3, 5, 5, 36, 2 nM for Flt1, KDR, Flt4, PDGFRα, PDGFRβ, c-Kit, respectively.
Web ID
– HY-13049
Storage Temperature
– 4°C (Powder, sealed storage, away from moisture)
Shipping
– Room Temperature
Applications
– Cancer-Kinase/protease
Molecular Formula
– C29H31FN4O7
References
– [1]Wedge SR, et al. AZD2171: a highly potent, orally bioavailable, vascular endothelial growth factor receptor-2 tyrosine kinase inhibitor for the treatment of cancer. Cancer Res, 2005, 65(10), 4389-4400.
CAS Number
– 857036-77-2
Molecular Weight
– 566.58
Compound Purity
– 99.84
SMILES
– O=C(O)/C=CC(O)=O.FC1=C(OC2=C(C(C=C3OCCCN4CCCC4)=NC=N2)C=C3OC)C=CC5=C1C=C(C)N5
Clinical Information
– Phase 3
Research Area
– Cancer
Solubility
– DMSO : ≥ 45 mg/mL|H2O : 2 mg/mL (ultrasonic)
Target
– Autophagy;PDGFR;VEGFR
Isoform
– PDGFRα;PDGFRβ;VEGFR1/Flt-1;VEGFR2/KDR/Flk-1;VEGFR3/Flt-4
Pathway
– Autophagy;Protein Tyrosine Kinase/RTK
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.